{"id":4141,"date":"2021-11-04T03:00:06","date_gmt":"2021-11-04T03:00:06","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=4141"},"modified":"2023-08-29T17:51:49","modified_gmt":"2023-08-29T17:51:49","slug":"invex-therapeutics-global-registration-presendin-treat-idiopathic-intracranial-hypertension","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=4141","title":{"rendered":"Invex Therapeutics\u5bfb\u6c42Presendin\u7684\u5168\u7403\u6ce8\u518c\uff0c\u4ee5\u6cbb\u7597\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b"},"content":{"rendered":"<p>\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u5df2\u8bc1\u5b9e\u5c06\u8fdb\u884c\u4e00\u9879III\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4ee5\u5b9e\u73b0\u5148\u5bfc\u836f\u7269Presendin\u5728\u5168\u7403\u6ce8\u518c\uff0c\u7528\u4e8e\u6cbb\u7597\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b(IIH)\u3002<\/p>\n<p>IIH Evolve\u8bd5\u9a8c\u5c06\u7279\u522b\u4fa7\u91cd\u4e8e\u6ee1\u8db3\u6b27\u76df\u3001\u82f1\u56fd\u548c\u6fb3\u5927\u5229\u4e9a\u7684\u5e02\u573a\u6279\u51c6\u8981\u6c42\uff0c\u91c7\u7528\u57fa\u4e8e\u6b27\u6d32\u836f\u54c1\u7ba1\u7406\u5c40(European Medicines Agency)\u5efa\u8bae\u7684\u8bbe\u8ba1\u3002<\/p>\n<p>\u6536\u96c6\u7684\u6570\u636e\u5c06\u8fdb\u4e00\u6b65\u4e3aPresendin\u5728\u7f8e\u56fd\u5e02\u573a\u7684\u540e\u7eed\u53d1\u5c55\u63d0\u4f9b\u4fe1\u606f\u3002<\/p>\n<h2>\u8bd5\u9a8c\u8bbe\u8ba1<\/h2>\n<p>Evolve\u8bd5\u9a8c\u5c06\u5728\u6b27\u6d32\u3001\u82f1\u56fd\u3001\u6fb3\u5927\u5229\u4e9a\u548c\u7f8e\u56fd\u768437\u4e2a\u4e2d\u5fc3\u62db\u52df240\u540d\u60a3\u8005\uff0c\u8fd9\u4e9b\u60a3\u8005\u5c06\u968f\u673a\u63a5\u53d7\u76ae\u4e0b\u6ce8\u5c04Presendin\u6216\u5b89\u6170\u5242\uff0c\u6bcf\u5468\u6ce8\u5c04\u4e00\u6b21\uff0c\u4e3a\u671f24\u5468\u3002<\/p>\n<p>\u4e3b\u8981\u7ec8\u70b9\u5c06\u8bc4\u4f30\u4ece\u57fa\u7ebf\u523024\u5468\u5185\u63a5\u53d7Presendin\u548c\u5b89\u6170\u5242\u7684\u60a3\u8005\u4e4b\u95f4\u7684\u9885\u5185\u538b\u7684\u5e73\u5747\u5dee\u5f02\u3002<\/p>\n<p>\u6b21\u8981\u7ec8\u70b9\u5c06\u8bc4\u4f30\u4e24\u7ec424\u5468\u5185\u89c6\u529b\u7684\u76f8\u5bf9\u5dee\u5f02(\u79f0\u4e3a\u5468\u5e73\u5747\u504f\u5dee\u548c\u4e73\u5934\u6c34\u80bf)\u548c\u6bcf\u6708\u5934\u75db\u5929\u6570(MHD)\u3002<\/p>\n<p>\u8bd5\u9a8c\u8d39\u7528\u5c06\u7531Invex\u73b0\u6709\u76843200\u4e07\u6fb3\u5143\u73b0\u91d1\u50a8\u5907\u63d0\u4f9b\uff0c\u62db\u8058\u9884\u8ba1\u9700\u8981\u5927\u7ea624\u4e2a\u6708\u7684\u65f6\u95f4\u3002<\/p>\n<p>Invex\u8868\u793a\uff0c\u5c06\u5728\u5e74\u5e95\u524d\u4efb\u547d\u4e00\u540d\u9996\u5e2d\u8c03\u67e5\u5458\uff0c\u5e76\u6267\u884c\u4e0e\u5173\u952e\u670d\u52a1\u63d0\u4f9b\u5546\u8fbe\u6210\u7684\u534f\u8bae\u3002<\/p>\n<p>\u6839\u636e\u6700\u8fd1\u4e0e<a href=\"http:\/\/smallcaps-production.test\/invex-therapeutics-signs-major-collaboration-with-peptron\/?lang=cn\">\u97e9\u56fd\u516c\u53f8Peptron Inc\u7684\u5408\u4f5c\u548c\u5236\u9020\u534f\u8bae\uff0c\u9996\u4e2a\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\u5c06\u540c\u65f6\u63d0\u4ea4<\/a>\uff0c\u5305\u542bPresendin\u7684\u975e\u4e34\u5e8a\u548c\u4e34\u5e8a\u4fe1\u606f\u3002<\/p>\n<p>Invex\u4e3b\u5e2dDr Jason Loveridge\u8868\u793a\uff0c\u8be5\u8bd5\u9a8c\u5c06\u662f\u4e00\u79cd\u201c\u6e05\u6670\u3001\u4f4e\u98ce\u9669\u7684\u65b9\u6cd5\u201d\uff0c\u4ee5\u5c3d\u5feb\u5c06Presendin\u63a8\u5411\u5e02\u573a\u3002<\/p>\n<h2>\u7981\u7528\u72b6\u6001<\/h2>\n<p>IIH\u7684\u7279\u70b9\u662f\u9885\u5185\u538b\u4e25\u91cd\u5347\u9ad8\uff0c\u5bfc\u81f4\u65e5\u5e38\u5934\u75db\u81f4\u6b8b\uff0c\u5e76\u53ef\u538b\u8feb\u89c6\u795e\u7ecf\u3002<\/p>\n<p>\u60a3\u8005\u901a\u5e38\u572830\u5c81\u4e4b\u524d\u9996\u6b21\u53d1\u75c5\uff0c\u8fd9\u79cd\u60c5\u51b5\u5728\u80a5\u80d6\u5973\u6027\u4e2d\u6700\u5e38\u89c1\u3002<\/p>\n<p>\u5728\u8fc7\u53bb10\u5e74\u91cc\uff0cIIH\u7684\u53d1\u75c5\u7387\u589e\u52a0\u4e86350%\u4ee5\u4e0a\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u5df2\u8bc1\u5b9e\u5c06\u8fdb\u884c\u4e00\u9879III\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4ee5\u5b9e\u73b0\u5148\u5bfc\u836f\u7269Presendin\u5728\u5168\u7403\u6ce8\u518c\uff0c\u7528\u4e8e\u6cbb\u7597\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b(IIH)\u3002 IIH Evolve\u8bd5\u9a8c\u5c06\u7279\u522b\u4fa7\u91cd\u4e8e\u6ee1\u8db3\u6b27\u76df\u3001\u82f1\u56fd\u548c\u6fb3\u5927\u5229\u4e9a\u7684\u5e02\u573a\u6279\u51c6\u8981\u6c42\uff0c\u91c7\u7528\u57fa\u4e8e\u6b27\u6d32\u836f\u54c1\u7ba1\u7406\u5c40(European Medicines Agency)\u5efa\u8bae\u7684\u8bbe\u8ba1\u3002 \u6536\u96c6\u7684\u6570\u636e\u5c06\u8fdb\u4e00\u6b65\u4e3aPresendin\u5728\u7f8e\u56fd\u5e02\u573a\u7684\u540e\u7eed\u53d1\u5c55\u63d0\u4f9b\u4fe1\u606f\u3002 \u8bd5\u9a8c\u8bbe\u8ba1 Evolve\u8bd5\u9a8c\u5c06\u5728\u6b27\u6d32\u3001\u82f1\u56fd\u3001\u6fb3\u5927\u5229\u4e9a\u548c\u7f8e\u56fd\u768437\u4e2a\u4e2d\u5fc3\u62db\u52df240\u540d\u60a3\u8005\uff0c\u8fd9\u4e9b\u60a3\u8005\u5c06\u968f\u673a\u63a5\u53d7\u76ae\u4e0b\u6ce8\u5c04Presendin\u6216\u5b89\u6170\u5242\uff0c\u6bcf\u5468\u6ce8\u5c04\u4e00\u6b21\uff0c\u4e3a\u671f24\u5468\u3002 \u4e3b\u8981\u7ec8\u70b9\u5c06\u8bc4\u4f30\u4ece\u57fa\u7ebf\u523024\u5468\u5185\u63a5\u53d7Presendin\u548c\u5b89\u6170\u5242\u7684\u60a3\u8005\u4e4b\u95f4\u7684\u9885\u5185\u538b\u7684\u5e73\u5747\u5dee\u5f02\u3002 \u6b21\u8981\u7ec8\u70b9\u5c06\u8bc4\u4f30\u4e24\u7ec424\u5468\u5185\u89c6\u529b\u7684\u76f8\u5bf9\u5dee\u5f02(\u79f0\u4e3a\u5468\u5e73\u5747\u504f\u5dee\u548c\u4e73\u5934\u6c34\u80bf)\u548c\u6bcf\u6708\u5934\u75db\u5929\u6570(MHD)\u3002 \u8bd5\u9a8c\u8d39\u7528\u5c06\u7531Invex\u73b0\u6709\u76843200\u4e07\u6fb3\u5143\u73b0\u91d1\u50a8\u5907\u63d0\u4f9b\uff0c\u62db\u8058\u9884\u8ba1\u9700\u8981\u5927\u7ea624\u4e2a\u6708\u7684\u65f6\u95f4\u3002 Invex\u8868\u793a\uff0c\u5c06\u5728\u5e74\u5e95\u524d\u4efb\u547d\u4e00\u540d\u9996\u5e2d\u8c03\u67e5\u5458\uff0c\u5e76\u6267\u884c\u4e0e\u5173\u952e\u670d\u52a1\u63d0\u4f9b\u5546\u8fbe\u6210\u7684\u534f\u8bae\u3002 \u6839\u636e\u6700\u8fd1\u4e0e\u97e9\u56fd\u516c\u53f8Peptron Inc\u7684\u5408\u4f5c\u548c\u5236\u9020\u534f\u8bae\uff0c\u9996\u4e2a\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\u5c06\u540c\u65f6\u63d0\u4ea4\uff0c\u5305\u542bPresendin\u7684\u975e\u4e34\u5e8a\u548c\u4e34\u5e8a\u4fe1\u606f\u3002 Invex\u4e3b\u5e2dDr Jason Loveridge\u8868\u793a\uff0c\u8be5\u8bd5\u9a8c\u5c06\u662f\u4e00\u79cd\u201c\u6e05\u6670\u3001\u4f4e\u98ce\u9669\u7684\u65b9\u6cd5\u201d\uff0c\u4ee5\u5c3d\u5feb\u5c06Presendin\u63a8\u5411\u5e02\u573a\u3002 \u7981\u7528\u72b6\u6001 IIH\u7684\u7279\u70b9\u662f\u9885\u5185\u538b\u4e25\u91cd\u5347\u9ad8\uff0c\u5bfc\u81f4\u65e5\u5e38\u5934\u75db\u81f4\u6b8b\uff0c\u5e76\u53ef\u538b\u8feb\u89c6\u795e\u7ecf\u3002 \u60a3\u8005\u901a\u5e38\u572830\u5c81\u4e4b\u524d\u9996\u6b21\u53d1\u75c5\uff0c\u8fd9\u79cd\u60c5\u51b5\u5728\u80a5\u80d6\u5973\u6027\u4e2d\u6700\u5e38\u89c1\u3002 \u5728\u8fc7\u53bb10\u5e74\u91cc\uff0cIIH\u7684\u53d1\u75c5\u7387\u589e\u52a0\u4e86350%\u4ee5\u4e0a\u3002<\/p>\n","protected":false},"author":4,"featured_media":13774,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[273],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Invex Therapeutics\u5bfb\u6c42Presendin\u7684\u5168\u7403\u6ce8\u518c\uff0c\u4ee5\u6cbb\u7597\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b<\/title>\n<meta name=\"description\" content=\"\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u5df2\u8bc1\u5b9e\u5c06\u8fdb\u884c\u4e00\u9879III\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4ee5\u5b9e\u73b0\u5148\u5bfc\u836f\u7269Presendin\u5728\u5168\u7403\u6ce8\u518c\uff0c\u7528\u4e8e\u6cbb\u7597\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b(IIH)\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Invex Therapeutics\u5bfb\u6c42Presendin\u7684\u5168\u7403\u6ce8\u518c\uff0c\u4ee5\u6cbb\u7597\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b\" \/>\n<meta property=\"og:description\" content=\"\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u5df2\u8bc1\u5b9e\u5c06\u8fdb\u884c\u4e00\u9879III\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4ee5\u5b9e\u73b0\u5148\u5bfc\u836f\u7269Presendin\u5728\u5168\u7403\u6ce8\u518c\uff0c\u7528\u4e8e\u6cbb\u7597\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b(IIH)\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-global-registration-presendin-treat-idiopathic-intracranial-hypertension\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-04T03:00:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:51:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Invex-Therapeutics-ASX-IVX-Presendin-Phase-3-clinical-trial-Idiopathic-Intracranial-Hypertension.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Imelda Cotton\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Imelda Cotton\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-global-registration-presendin-treat-idiopathic-intracranial-hypertension\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-global-registration-presendin-treat-idiopathic-intracranial-hypertension\/\",\"name\":\"Invex Therapeutics\u5bfb\u6c42Presendin\u7684\u5168\u7403\u6ce8\u518c\uff0c\u4ee5\u6cbb\u7597\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2021-11-04T03:00:06+00:00\",\"dateModified\":\"2023-08-29T17:51:49+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\"},\"description\":\"\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u5df2\u8bc1\u5b9e\u5c06\u8fdb\u884c\u4e00\u9879III\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4ee5\u5b9e\u73b0\u5148\u5bfc\u836f\u7269Presendin\u5728\u5168\u7403\u6ce8\u518c\uff0c\u7528\u4e8e\u6cbb\u7597\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b(IIH)\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-global-registration-presendin-treat-idiopathic-intracranial-hypertension\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-global-registration-presendin-treat-idiopathic-intracranial-hypertension\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-global-registration-presendin-treat-idiopathic-intracranial-hypertension\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Invex Therapeutics\u5bfb\u6c42Presendin\u7684\u5168\u7403\u6ce8\u518c\uff0c\u4ee5\u6cbb\u7597\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\",\"name\":\"Imelda Cotton\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"caption\":\"Imelda Cotton\"},\"description\":\"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=4\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Invex Therapeutics\u5bfb\u6c42Presendin\u7684\u5168\u7403\u6ce8\u518c\uff0c\u4ee5\u6cbb\u7597\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b","description":"\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u5df2\u8bc1\u5b9e\u5c06\u8fdb\u884c\u4e00\u9879III\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4ee5\u5b9e\u73b0\u5148\u5bfc\u836f\u7269Presendin\u5728\u5168\u7403\u6ce8\u518c\uff0c\u7528\u4e8e\u6cbb\u7597\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b(IIH)\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Invex Therapeutics\u5bfb\u6c42Presendin\u7684\u5168\u7403\u6ce8\u518c\uff0c\u4ee5\u6cbb\u7597\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b","og_description":"\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u5df2\u8bc1\u5b9e\u5c06\u8fdb\u884c\u4e00\u9879III\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4ee5\u5b9e\u73b0\u5148\u5bfc\u836f\u7269Presendin\u5728\u5168\u7403\u6ce8\u518c\uff0c\u7528\u4e8e\u6cbb\u7597\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b(IIH)\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-global-registration-presendin-treat-idiopathic-intracranial-hypertension\/","og_site_name":"smallcapsCN","article_published_time":"2021-11-04T03:00:06+00:00","article_modified_time":"2023-08-29T17:51:49+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Invex-Therapeutics-ASX-IVX-Presendin-Phase-3-clinical-trial-Idiopathic-Intracranial-Hypertension.jpg","type":"image\/jpeg"}],"author":"Imelda Cotton","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Imelda Cotton"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-global-registration-presendin-treat-idiopathic-intracranial-hypertension\/","url":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-global-registration-presendin-treat-idiopathic-intracranial-hypertension\/","name":"Invex Therapeutics\u5bfb\u6c42Presendin\u7684\u5168\u7403\u6ce8\u518c\uff0c\u4ee5\u6cbb\u7597\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2021-11-04T03:00:06+00:00","dateModified":"2023-08-29T17:51:49+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e"},"description":"\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u5df2\u8bc1\u5b9e\u5c06\u8fdb\u884c\u4e00\u9879III\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4ee5\u5b9e\u73b0\u5148\u5bfc\u836f\u7269Presendin\u5728\u5168\u7403\u6ce8\u518c\uff0c\u7528\u4e8e\u6cbb\u7597\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b(IIH)\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-global-registration-presendin-treat-idiopathic-intracranial-hypertension\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/invex-therapeutics-global-registration-presendin-treat-idiopathic-intracranial-hypertension\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-global-registration-presendin-treat-idiopathic-intracranial-hypertension\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Invex Therapeutics\u5bfb\u6c42Presendin\u7684\u5168\u7403\u6ce8\u518c\uff0c\u4ee5\u6cbb\u7597\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e","name":"Imelda Cotton","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","caption":"Imelda Cotton"},"description":"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.","url":"https:\/\/smallcapscn.x5view.co\/?author=4"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/4141"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4141"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/4141\/revisions"}],"predecessor-version":[{"id":13773,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/4141\/revisions\/13773"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/13774"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4141"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4141"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4141"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}